Rankings
▼
Calendar
IRWD Q2 2022 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$629M
Q2 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$97M
-6.5% YoY
Gross Profit
$97M
99.6% margin
Operating Income
$56M
57.2% margin
Net Income
$37M
38.1% margin
EPS (Diluted)
$0.21
QoQ Revenue Growth
-0.3%
Cash Flow
Operating Cash Flow
$61M
Free Cash Flow
$61M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$976M
Total Liabilities
$443M
Stockholders' Equity
$533M
Cash & Equivalents
$506M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$97M
$104M
-6.5%
Gross Profit
$97M
$92M
+5.4%
Operating Income
$56M
$65M
-14.5%
Net Income
$37M
$391M
-90.5%
Revenue Segments
Collaborative arrangements revenue
$97M
99%
Collaborative arrangement, co-promotion agreements
$585,000
1%
Collaborative arrangement, other agreements
$409,000
0%
Collaborative arrangement, collaboration and license agreements
$148,000
0%
Geographic Segments
North America
$609,000
50%
Canada and Mexico
$600,000
50%
← FY 2022
All Quarters
Q3 2022 →